Published in Clin Infect Dis on November 01, 1992
Pathogenesis of Escherichia coli diarrhea. N Engl J Med (1971) 10.36
Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun (1978) 5.71
Typhoid fever: pathogenesis and immunologic control. N Engl J Med (1970) 4.95
Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. Am J Public Health (1994) 4.79
Hemagglutination patterns of enterotoxigenic and enteropathogenic Escherichia coli determined with human, bovine, chicken, and guinea pig erythrocytes in the presence and absence of mannose. Infect Immun (1979) 4.60
The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo. Mol Cancer Ther (2001) 4.37
The validity of smoking self-reports by adolescents: a reexamination of the bogus pipeline procedure. Addict Behav (1987) 4.37
Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore) (1969) 4.20
Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. N Engl J Med (1976) 3.82
Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis (1981) 3.76
Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol (1997) 3.70
Measurement of adolescent smoking behavior: rationale and methods. J Behav Med (1984) 3.70
Systematic risk factor screening and education: a community-wide approach to prevention of coronary heart disease. Prev Med (1986) 3.69
A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA (1994) 3.66
Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis (1973) 3.45
Smoking prevalence in a cohort of adolescents, including absentees, dropouts, and transfers. Am J Public Health (1988) 3.27
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13
Inactivation of Norwalk virus in drinking water by chlorine. Appl Environ Microbiol (1985) 3.12
Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis (1974) 3.10
Communitywide smoking prevention: long-term outcomes of the Minnesota Heart Health Program and the Class of 1989 Study. Am J Public Health (1992) 3.09
Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis (2001) 3.08
Patterns of loss of enterotoxigenicity by Escherichia coli isolated from adults with diarrhea: suggestive evidence for an interrelationship with serotype. Infect Immun (1977) 3.04
The effects of community policies to reduce youth access to tobacco. Am J Public Health (1998) 2.99
A newly recognized cause of travelers' diarrhea: enteroadherent Escherichia coli. J Infect Dis (1985) 2.94
Comparative susceptibility of latin american and united states students to enteric pathogens. N Engl J Med (1976) 2.94
Saliva thiocyanate: a chemical indicator of cigarette smoking in adolescents. Am J Public Health (1981) 2.88
Sources of alcohol for underage drinkers. J Stud Alcohol (1996) 2.81
Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen. Infect Immun (1978) 2.78
Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect (2010) 2.77
Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N Engl J Med (1982) 2.71
Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J Infect Dis (1999) 2.65
Role of Escherichia coli colonisation factor antigen in acute diarrhoea. Lancet (1978) 2.65
Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis (1990) 2.63
Typhoid fever: pathogenesis and immunologic control. 2. N Engl J Med (1970) 2.63
Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters. Rev Infect Dis (1980) 2.59
Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis (1977) 2.57
Adverse effect of lomotil therapy in shigellosis. JAMA (1973) 2.57
Communities mobilizing for change on alcohol: outcomes from a randomized community trial. J Stud Alcohol (2000) 2.53
Virulence factors of enterotoxigenic Escherichia coli. J Infect Dis (1977) 2.45
Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections. Infect Control (1981) 2.43
Comparison of two assay methods for patterns of adherence to HEp-2 cells of Escherichia coli from patients with diarrhea. J Clin Microbiol (1990) 2.43
Clindamycin-induced enterocolitis in hamsters. J Infect Dis (1978) 2.43
The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest (1991) 2.42
Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol (1999) 2.40
Pathogenicity of enteroadherent Escherichia coli in adult volunteers. J Infect Dis (1986) 2.32
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect (2008) 2.30
Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J Infect Dis (1972) 2.29
A meta-analysis of smoking prevention programs after adjustment for errors in the unit of analysis. Health Educ Q (1996) 2.29
Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. N Engl J Med (1982) 2.27
Diarrhea caused by Shigella, rotavirus, and Giardia in day-care centers: prospective study. J Pediatr (1981) 2.21
Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens. Antimicrob Agents Chemother (1983) 2.20
Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth). JAMA (1980) 2.16
Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment. Am J Med (1981) 2.08
The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis (2000) 2.06
The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer. Cancer Res (2001) 2.06
The response of man to virulent Shigella flexneri 2a. J Infect Dis (1969) 1.97
Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1987) 1.93
Detection of enteric viruses in treated drinking water. Appl Environ Microbiol (1984) 1.87
Adolescent smokers' provision of tobacco to other adolescents. Am J Public Health (1997) 1.85
Gender differences in cigarette smoking and quitting in a cohort of young adults. Am J Public Health (1991) 1.83
Prospective study of enteropathogens in children with diarrhea in Houston and Mexico. J Pediatr (1978) 1.82
Immunity in typhoid fever: evaluation of live streptomycin-dependent vaccine. Antimicrob Agents Chemother (Bethesda) (1970) 1.82
Occurrence of Giardia lamblia in children in day care centers. J Pediatr (1984) 1.82
Parent involvement with children's health promotion: the Minnesota Home Team. Am J Public Health (1988) 1.82
Process evaluation in a multisite, primary obesity-prevention trial in American Indian schoolchildren. Am J Clin Nutr (1999) 1.81
Treatment of falciparum malaria caused by strain resistant to quinine. JAMA (1970) 1.81
Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin. Gastroenterology (1979) 1.80
An organizational strategy to improve adolescent measles-mumps-rubella vaccination in a low socioeconomic population. A method to reduce missed opportunities. Arch Fam Med (1994) 1.80
Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infect Immun (1985) 1.80
Clinical approach to infectious diarrheas. Medicine (Baltimore) (1973) 1.75
Production of heat-stable, methanol-soluble enterotoxin by Yersinia enterocolitica. Infect Immun (1979) 1.73
Studies on the epidemiology of antibiotic-associated Clostridium difficile colitis. Am J Clin Nutr (1980) 1.73
Risk and aetiology of diarrhoea at various tourist destinations. Lancet (2000) 1.72
A community education monitoring system: methods from the Stanford Five-City Project, the Minnesota Heart Health Program and the Pawtucket Heart Health Program. Health Educ Res (1993) 1.70
The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditis. J Antimicrob Chemother (1987) 1.69
Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol (1988) 1.69
Commercial availability of alcohol to young people: results of alcohol purchase attempts. Prev Med (1995) 1.68
Validity of telephone surveys in assessing cigarette smoking in young adults. Am J Public Health (1989) 1.68
Cryptosporidium, isospora and strongyloides in AIDS. Natl Med J India (1996) 1.67
Enteropathogenic Escherichia coli: lack of correlation of serotype with pathogenicity. J Infect Dis (1976) 1.65
Perceived and measured availability of tobacco to youths in 14 Minnesota communities: the TPOP Study. Tobacco Policy Options for Prevention. Am J Prev Med (1997) 1.64
Communities mobilizing for change on alcohol (CMCA): effects of a randomized trial on arrests and traffic crashes. Addiction (2000) 1.63
Outbreaks of diarrhea associated with Clostridium difficile and its toxin in day-care centers: evidence of person-to-person spread. J Pediatr (1983) 1.63
The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens following experimental infection in humans. J Infect Dis (1998) 1.61
Intraclass correlation for measures from a worksite health promotion study: estimates, correlates, and applications. Am J Health Promot (1999) 1.59
Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect Immun (1998) 1.59
Changing fruit and vegetable consumption among children: the 5-a-Day Power Plus program in St. Paul, Minnesota. Am J Public Health (1998) 1.59
A simple method for concentration of enteroviruses and rotaviruses from cell culture harvests using membrane filters. Intervirology (1978) 1.58
Predictors of weight gain in the Pound of Prevention study. Int J Obes Relat Metab Disord (2000) 1.57
The relation between production of cytotoxin and clinical features in shigellosis. J Infect Dis (1986) 1.54
Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases. J Infect Dis (1982) 1.53
Community education for cardiovascular disease prevention. Morbidity and mortality results from the Minnesota Heart Health Program. Am J Epidemiol (1996) 1.53
Enteropathogens associated with pediatric diarrhea in Mexico City. J Pediatr (1977) 1.53
Prevention of cigarette smoking: three-year follow-up of an education program for youth. J Behav Med (1983) 1.52
Clostridium difficile colitis associated with cancer chemotherapy. Arch Intern Med (1982) 1.51
Reconciling conflicting findings regarding postcessation weight concerns and success in smoking cessation. Health Psychol (2000) 1.51
Joint analysis of three U.S. community intervention trials for reduction of cardiovascular disease risk. J Clin Epidemiol (1997) 1.45
Fecal leukocytes in enteric infections. Am J Clin Pathol (1977) 1.44
Evaluation of new anti-infective drugs for the treatment of gastritis and peptic ulcer disease associated with infection by Helicobacter pylori. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.44